Construction of A Nomogram Prediction Model for PD-L1 Expression in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters.
Background and objective In recent years, immunotherapy represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly changed the status of non-small cell lung cancer (NSCLC) treatment. PD-L1 has become an important biomarker for screening NSCLC...
| Publicado en: | Chinese Journal of Lung Cancer Vol. 26; no. 11; pp. 833 - 843 |
|---|---|
| Autores principales: | , , , , |
| Formato: | diagnostic images research tables/charts Journal Article |
| Publicado: |
Chinese Journal of Lung Cancer
Nov2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |